Hospital transfer after a breast cancer diagnosis

التفاصيل البيبلوغرافية
العنوان: Hospital transfer after a breast cancer diagnosis
المؤلفون: Heeg, E., Schreuder, K., Spronk, P.E.R., Oosterwijk, J.C., Marang-van de Mheen, P.J., Siesling, S., Peeters, M.T.F.D.V., NABON Breast Canc Audit
المساهمون: Damage and Repair in Cancer Development and Cancer Treatment (DARE), Targeted Gynaecologic Oncology (TARGON), Health Technology & Services Research
المصدر: EJSO-European Journal of Surgical Oncology, 45(4), 560-566. ELSEVIER SCI LTD
EJSO, 45(4), 560-566. ELSEVIER SCI LTD
European journal of surgical oncology, 45(4), 560-566. Elsevier
سنة النشر: 2019
مصطلحات موضوعية: medicine.medical_treatment, Mammaplasty, CONTINUITY, DELAYS, Mastectomy, Segmental, 0302 clinical medicine, Breast cancer, 030212 general & internal medicine, Registries, Netherlands, Aged, 80 and over, OUTCOMES, Age Factors, Treatment delay, ASSOCIATION, General Medicine, Middle Aged, Neoadjuvant Therapy, Oncology, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, FRAGMENTATION, Mastectomy, Adult, Patient Transfer, medicine.medical_specialty, Time to treatment, Breast Neoplasms, Time-to-Treatment, 03 medical and health sciences, Internal medicine, MASTECTOMY, medicine, QUALITY, Humans, RECONSTRUCTION, Hospital transfer, Aged, Chemotherapy, business.industry, 22/3 OA procedure, CARE, medicine.disease, Discontinue of care, Cancer registry, Population based study, Propensity score matching, Surgery, business
الوصف: PURPOSE:Patients may transfer of hospital for clinical reasons but this may delay time to treatment. The purpose ofthis study is to provide insight in the extent of hospital transfer in breast cancer care; which type of patients transfer and what is the impact on time to treatment.METHODS:We included 41,413 breast cancer patients registered in the Netherlands Cancer Registry between 2014and 2016. We investigated transfer of hospital between diagnosis and first treatment being surgery or neoadjuvant chemotherapy (NAC). Co-variate adjusted characteristics predictive for hospital transfer were determined. To adjust for possible treatment by indication bias we used propensity score matching (PSM). Time to treatment in patients with and without hospital transfer was compared.RESULTS:Among 41,413 patients, 8.5% of all patients transferred to another hospital between diagnosis and firsttreatment; 4.9% before primary surgery and 24.8% before NAC. Especially young (aged CONCLUSIONS:While almost 5% of Dutch patients treated with primary surgery transfer hospital after diagnosis andup to 25% for patients treated with NAC, our findings suggest that especially those treated with primary surgery are at risk for additional treatment delay by hospital transfer.
وصف الملف: application/pdf
اللغة: English
تدمد: 0748-7983
DOI: 10.1016/j.ejso.2018.12.017
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb11cd71a3902e6a272b28f1fb8208a7
https://doi.org/10.1016/j.ejso.2018.12.017
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....bb11cd71a3902e6a272b28f1fb8208a7
قاعدة البيانات: OpenAIRE
الوصف
تدمد:07487983
DOI:10.1016/j.ejso.2018.12.017